Ronald C. Walker, M.D.
Professor of Clinical Radiology & Radiological Sciences
Department of Radiology and Radiological Sciences
1121 21st Avenue South
Nashville, TN 37232-2675
My research is focused on molecular imaging of cancer both to improve early and accurate diagnosis and to provide rapid assessment of tumor biology with physiological imaging, and on radiation therapy for cancer based on targeted molecular receptors within or on the cancer cell.
My research is focused on molecular imaging of cancer both to improve early and accurate diagnosis and to provide rapid assessment of tumor biology with physiological imaging, and on radiation therapy for cancer based on targeted molecular receptors within or on the cancer cell. I hope, with my collaborators, to use new tools to identify the risk level of an tumor at time of diagnosis, thus allowing up-front treatment decisions that will provide superior, safer and more cost-effective treatment strategies for each patient. I also work to discover new insights into tumor biology that will bring new opportunities for treatment, such as with peptide-receptor radiotherapy (PRRT). Importantly, I always consider if my research can lead to improvements in medical care that can ultimately be deployed with affordable, preferably off-the-shelf technology, in community hospitals throughout the US so that everyone can ultimately and quickly benefit from the contributions I am able to make to the care of patients suffering from cancer.
- BS Biology, Baylor University 1974
- MD Baylor College of Medicine 1978
- Flexible Internship Scott USAF Medical Center 1978-1979
- Radiology Residency Wilford Hall USAF Medical Center 1979-1982
- Nuclear Medicine Fellowship Univ of Texas San Antonio 1982 - 1984
PET Imaging and Research, PET-CT in Oncology and Myocardial Perfusion
PET imaging and research, particularly in multiple myeloma; PET-CT in oncology; PET-CT in myocardial perfusion; SPECT-CT for myocardial perfusion with or without CT angiography; Graduate medical education in Nuclear Medicine, especially in PET-CT and CT
- Walker, RC, Brown, TL, Jones-Jackson, LB, De Blanche, L, Bartel, T Imaging of multiple myeloma and related plasma cell dyscrasias. J Nucl Med, 53(7), 1091-101, 2012.
- McKinley, ET, Smith, RA, Tanksley, JP, Washington, MK, Walker, R, Coffey, RJ, Manning, HC [18F]FLT-PET to predict pharmacodynamic and clinical response to cetuximab therapy in Menetrier's disease. Ann Nucl Med, 26(9), 757-63, 2012.
- Deppen, S, Putnam, JB, Andrade, G, Speroff, T, Nesbitt, JC, Lambright, ES, Massion, PP, Walker, R, Grogan, EL Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease. Ann Thorac Surg, 92(2), 428-32; discussion 433, 2011.
- Grogan, EL, Weinstein, JJ, Deppen, SA, Putnam, JB, Nesbitt, JC, Lambright, ES, Walker, RC, Dittus, RS, Massion, PP Thoracic operations for pulmonary nodules are frequently not futile in patients with benign disease. J Thorac Oncol, 6(10), 1720-5, 2011.
- Bartel, TB, Haessler, J, Brown, TL, Shaughnessy, JD, van Rhee, F, Anaissie, E, Alpe, T, Angtuaco, E, Walker, R, Epstein, J, Crowley, J, Barlogie, B F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma. Blood, 114(10), 2068-76, 2009.
- Shaughnessy, JD, Zhan, F, Burington, BE, Huang, Y, Colla, S, Hanamura, I, Stewart, JP, Kordsmeier, B, Randolph, C, Williams, DR, Xiao, Y, Xu, H, Epstein, J, Anaissie, E, Krishna, SG, Cottler-Fox, M, Hollmig, K, Mohiuddin, A, Pineda-Roman, M, Tricot, G, van Rhee, F, Sawyer, J, Alsayed, Y, Walker, R, Zangari, M, Crowley, J, Barlogie, B A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood, 109(6), 2276-84, 2007.
- Yaccoby, S, Ling, W, Zhan, F, Walker, R, Barlogie, B, Shaughnessy, JD Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo. Blood, 109(5), 2106-11, 2007.
- King, DL, Stack, BC, Spring, PM, Walker, R, Bodenner, DL Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas. Otolaryngol Head Neck Surg, 137(3), 400-4, 2007.
- Walker, R, Barlogie, B, Haessler, J, Tricot, G, Anaissie, E, Shaughnessy, JD, Epstein, J, van Hemert, R, Erdem, E, Hoering, A, Crowley, J, Ferris, E, Hollmig, K, van Rhee, F, Zangari, M, Pineda-Roman, M, Mohiuddin, A, Yaccoby, S, Sawyer, J, Angtuaco, EJ Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications. J Clin Oncol, 25(9), 1121-8, 2007.
- Walker, RC, Jones-Jackson, LB, Martin, W, Habibian, MR, Delbeke, D New imaging tools for the diagnosis of infection. Future Microbiol, 2(5), 527-54, 2007.
- Mahfouz T, Miceli MH, Saghafifar F, Stroud S, Jones-Jackson L, Walker R, et al. "18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodes." Journal of Clinical Oncology, (23), 7857-7863, 2005.
- Miceli MH, Atoui R, Walker R, et al. "Diagnosis of deep septic thrombophlebitis in cancer patients by Fluorine-18 fluorodeoxyglucose positron emission tomography scanning: a preliminary report." Journal of Clinical Oncology, (22), 1949-1956, 2004.
- Angtuaco EJC, Fassas AB, Walker RC, Sethi R, Barlogie B "Multiple myeloma: clinical review and diagnostic imaging." Radiology, (231), 11-23, 2004.
- Maxwell C, Rasmussen E, Zhan F, Keats J, Adamia S, Strachan E, Crainie M, Walker, R, et al. "RHAMM expression and isoform balance predicts aggressive disease and poor survival in multiple myeloma." Blood, (104), 1151-1158, 2004.
- Barlogie B, Shaughnessy J, Tricot G, Jacobson J, Zangari M, Anaissie E, Walker R, Crowley J "Treatment of multiple myeloma." Blood, (103), 20-32, 2004.
- Walker RC, Barlogie B, Shaughnessy J "Letter to the Editor regarding N Eng J Med 349:2483-2494, 2003." New England Journal of Medicine, 14(350), 1465, 2003.
- Walker RC, Zigler SS "PET practice in nuclear pharmacy.." Journal American Pharmacists Association, (32), S42-3, 2003.
- Tian E, Zhan F, Walker R, et al. "The role of the Wn/Î²-catenin signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma.." New England Journal of Medicine, (349), 2483-2494, 2003.
- Walker RC, Weiss DW, Purnell GL, Forte KF "Positron emisson tomography scanning: a primer.." Journal of the Arkansas Medical Society, 4(99), 119-121, 2002.